Maleimide Functionalized Polycaprolactone Micelles for Glutathione Quenching and Doxorubicin Delivery

Mihaela C. Stefan,Godwin Babanyinah,Abhi Bhadran,Hanghang Wang,Tejas Shah,Michael C Biewer,Himanshu Polara

DOI: https://doi.org/10.1039/d4sc01625d

IF: 8.4

2024-05-26

Chemical Science

Abstract:High glutathione production is known to be one of the defense mechanisms by which many cancer cells survive elevated oxidative stress. By specifically targeting glutathione in these cancer cells and diminishing its levels, oxidative stress can be intensified, ultimately triggering apoptosis or programmed cell death. Herein, we developed a novel approach by creating maleimide-functionalized polycaprolactone polymers, specifically using 2,3-diiodomaleimide functionality to reduce the level of glutathione (GSH) in cancer cells. Polycaprolactone was chosen to conjugate the 2,3-diiodomaleimide functionality due to its biodegradable and biocompatible properties. The amphiphilic block copolymer was synthesized using polyethylene glycol (PEG) as a macroinitiator to make corresponding polymeric micelles. The resulting 2,3-diiodomaleimide-conjugated polycaprolactone micelles effectively quenched glutathione, even at low concentrations (0.01 mg/mL). Furthermore, we loaded these micelles with the anticancer drug doxorubicin (DOX), which exhibited pH-dependent drug release. We obtained a loading capacity (LC) of 3.5 % for the micelles, one of the highest LC reported among functional PCL-based micelles. Moreover, the enhanced LC has not affected their release profile. Cytotoxicity experiments demonstrated that empty and DOX-loaded micelles inhibited cancer cell growth, with the DOX-loaded micelles displaying the highest cytotoxicity. The ability of the polymer to quench intracellular GSH was also confirmed. This approach of attaching maleimide to polycaprolactone polymers shows promise in depleting elevated glutathione levels in cancer cells, potentially improving cancer treatment efficacy.

chemistry, multidisciplinary